Syra Health Share Holder Equity 2022-2025 | SYRA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Syra Health share holder equity from 2022 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Syra Health share holder equity from 2022 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$47.8B
Hims & Hers Health (HIMS)	$13.1B
Doximity (DOCS)	$11.5B
Tempus AI (TEM)	$10.7B
IRhythm Technologies (IRTC)	$4.4B
Inspire Medical Systems (INSP)	$3.9B
Hinge Health (HNGE)	$3.5B
Privia Health (PRVA)	$2.4B
10x Genomics (TXG)	$1.8B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.6B
Azenta (AZTA)	$1.6B
Enovis (ENOV)	$1.6B
Clover Health Investments (CLOV)	$1.5B
Omnicell (OMCL)	$1.4B
Evolent Health (EVH)	$1.1B
Claritev (CTEV)	$664M
Fulgent Genetics (FLGT)	$549M
Standard BioTools (LAB)	$539M
Veradigm (MDRX)	$507M
Butterfly Network (BFLY)	$480M
Talkspace (TALK)	$428M
TruBridge (TBRG)	$347M
Outset Medical (OM)	$320M
Health Catalyst (HCAT)	$285M
Nyxoah SA (NYXH)	$244M
SOPHiA GENETICS SA (SOPH)	$224M
CapsoVision (CV)	$202M
Zepp Health (ZEPP)	$199M
KORU Medical Systems (KRMD)	$157M